CHEBI:176844 - niraparib

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name niraparib
ChEBI ID CHEBI:176844
Definition A 2-[4-(piperidin-3-yl)phenyl]-2H-indazole-7-carboxamide that has S-configuration. It is a potent inhibitor of PARP1 and PARP2 (IC50 of 3.8 and 2.1 nM, respectively) and approved as a first-line maintenance treatment for women with advanced ovarian cancer after responding to platinum-based chemotherapy.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Ceara Rea
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C19H20N4O
Net Charge 0
Average Mass 320.396
Monoisotopic Mass 320.16371
InChI InChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1
InChIKey PCHKPVIQAHNQLW-CQSZACIVSA-N
SMILES [H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1
Roles Classification
Biological Role(s): EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
An EC 2.4.2.* (pentosyltransferase) inhibitor that interferes with the action of a NAD+ ADP-ribosyltransferase (EC 2.4.2.30).
(via 2-[4-(piperidin-3-yl)phenyl]-2H-indazole-7-carboxamide )
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
(via 2-[4-(piperidin-3-yl)phenyl]-2H-indazole-7-carboxamide )
radiosensitizing agent
A drug that makes increases the sensitivity of tumour cells to radiation therapy.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing niraparib (CHEBI:176844) has role antineoplastic agent (CHEBI:35610)
niraparib (CHEBI:176844) has role apoptosis inducer (CHEBI:68495)
niraparib (CHEBI:176844) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913)
niraparib (CHEBI:176844) has role radiosensitizing agent (CHEBI:132992)
niraparib (CHEBI:176844) is a 2-[4-(piperidin-3-yl)phenyl]-2H-indazole-7-carboxamide (CHEBI:177298)
IUPAC Name
2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide
INNs Sources
niraparib WHO MedNet
niraparib WHO MedNet
niraparib WHO MedNet
niraparibum WHO MedNet
Synonyms Sources
2-[4-(3S)-3-piperidinylphenyl]-2H-indazole-7-carboxamide ChEBI
2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide ChEBI
MK 4827 ChemIDplus
MK-4827 SUBMITTER
MK4827 ChEBI
Brand Name Source
Zejula DrugBank
Manual Xrefs Databases
24531930 ChemSpider
3JD PDBeChem
5222 DrugCentral
D10140 KEGG DRUG
DB11793 DrugBank
KR20100114021 Patent
Niraparib Wikipedia
View more database links
Registry Number Type Source
1038915-60-4 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
19873981 PubMed citation Europe PMC
23482742 PubMed citation Europe PMC
24970803 PubMed citation Europe PMC
28001384 PubMed citation Europe PMC
29081841 PubMed citation Europe PMC
29214031 PubMed citation Europe PMC
29856239 PubMed citation Europe PMC
30096696 PubMed citation Europe PMC
31857852 PubMed citation Europe PMC
32073931 PubMed citation Europe PMC
32679152 PubMed citation Europe PMC
32753559 PubMed citation Europe PMC
32863940 PubMed citation Europe PMC
33361107 PubMed citation Europe PMC
33407715 PubMed citation Europe PMC
33470063 PubMed citation Europe PMC
33545804 PubMed citation Europe PMC
33559417 PubMed citation Europe PMC
33621324 PubMed citation Europe PMC
33641880 PubMed citation Europe PMC
33691564 PubMed citation Europe PMC
33774805 PubMed citation Europe PMC
33905671 PubMed citation Europe PMC
33915252 PubMed citation Europe PMC
33920140 PubMed citation Europe PMC
33993885 PubMed citation Europe PMC
34073147 PubMed citation Europe PMC
34164503 PubMed citation Europe PMC
34241562 PubMed citation Europe PMC
34307148 PubMed citation Europe PMC
34324028 PubMed citation Europe PMC
34327724 PubMed citation Europe PMC
Last Modified
06 August 2021